Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria

Clinical trial NCT02023164 · COMPLETED

Trial details

NCT number: NCT02023164
Sponsor: JDP Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Urticaria

Start date: 2013-07-01
Primary completion: 2014-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.